Physician Assistant CME

In this online, self-learning activity: Blepharitis is a condition characterized by inflammation of the eyelids, resulting in discomfort, redness, irritation, and the appearance of dandruff-like flakes on eyelashes. Demodex blepharitis is a specific subtype of blepharitis, where blepharitis is caused by an overgrowth of Demodex mites, which are normal facial skin flora. In other forms of blepharitis, the etiology may be bacterial colonization, allergies, or seborrheic dermatitis, whereas in Demodex blepharitis, the excessive growth of Demodex folliculorum or Demodex brevis is the driver of inflammation. Research suggests that Demodex blepharitis represents three out of five cases of blepharitis.

In this accredited activity, expert faculty, Adjoa Anyane‐Yeboa, MD, MPH, and Ugo Iroku, MD, MHS, dive into the issue of healthcare disparities in inflammatory bowel disease (IBD).

Healthcare disparities disproportionately affect minoritized and low-income groups, contributing to poor health outcomes. Patient-provider distrust, knowledge gaps, and lack of shared decision making contribute to health disparities in these patient groups and influence disease outcomes. It is critical for clinicians to understand the social determinants of health impacting IBD patient care and develop strategies to reduce disparities. In addition, implicit bias significantly affects clinician-patient interaction, as well as diagnosis and treatment decisions. Once clinicians are made aware of their implicit biases, they must work to overcome them and foster open communication with patients to reduce disparities and improve patient care.

In this online, self-learning activity:

Over the past few decades, cultural competence has been defined in a variety of ways, including in the recent appearance of the closely related terms, cultural humility and cultural competemility. According to the Centers for Disease Control and Prevention, cultural competence is a “set of congruent behaviors, attitudes, and policies that come together in a system, agency, or among professionals that enables effective work in cross-cultural situations.” In the setting of healthcare, practicing cultural competence can improve the ability of HCPs to meet the social, cultural, and linguistic needs of patients, which may ultimately improve provider competence and health outcomes among diverse groups of patients with unique sociocultural identities, including race, ethnicity, gender, and sexual orientation.

Pri-Med offers a diverse library of physician assistant CME/CE, providing clinically focused education for every stage of your career. Whether you’re a newly practicing physician assistant transitioning from the classroom to the exam room or an experienced clinician, you’ll find the resources you need to grow professionally.

This on-demand webinar provides a comprehensive overview of Pain Reprocessing Therapy, Emotional Awareness and Expression Therapy, and related approaches. Led by Yoni K. Ashar, PhD, this course explores the key distinctions between pain recovery therapies and traditional pain management, offering practical tools to help patients achieve lasting relief.

Physicians, psychologists, and healthcare professionals will benefit from this evidence-based training, earning 1 CME or CEU upon completion.

In this 1-hour (chapter-based) presentation, join a primary care practitioner and an obesity specialist as they navigate real-world conversations about weight management. Explore effective pharmacologic options and gain confidence in initiating weight loss discussions.

Early identification of atypical motor patterns is crucial for timely intervention and optimizing developmental outcomes in infants. A simple yet effective method for assessing these patterns involves observing the baby during a 30-second, 4-position exam. This examination includes careful observation of the infant in the following positions:

* Supine: Note posture, spontaneous movements, and interaction with the environment.

* Horizontal Suspension: Observe head control, trunk extension, and limb movements against gravity.

* Pull to Sit: Assess head lag, trunk activation, and ability to assist with the movement.

* Prone: Evaluate head lifting, weight-bearing through the arms, and early mobility attempts. Gain valuable insights and download resources through this complimentary CME/CE course

In this accredited CME/CNE activity, cardiologist Dr. Matthew Martinez reviews key considerations and updates in the diagnosis and management of hypertrophic cardiomyopathy (HCM). Specifically, he explores the disease burden and the dire consequences of undiagnosed HCM, the difficulty in diagnosing HCM including lack of symptoms or presence of nonspecific symptoms, best practices for ordering echocardiograms, and guideline recommendations for treatment, including mavacamten. The informational session also discusses communicating with patients and caregivers/families.

Acromegaly is an endocrine disorder characterized by dysregulated hypersecretion of growth hormone (GH), usually caused by a GH-secreting, pituitary adenoma and leading to an overproduction of insulin-like growth factor 1 (IGF-1). Estimated to have a prevalence of 2.8 to 13.7 cases per 100,000, acromegaly is not as common as other endocrine disorders. However, its incidence is increasing, and it has a significant impact on patient quality of life, with clinical features that include: acral enlargement; facial feature and oral changes; headache; significant fatigue, including daytime sleepiness; hyperhidrosis; oily and thicker skin; weight gain; and arthralgia. Approximately 25 percent of people with acromegaly have elevated blood pressure, and 50 percent have evidence of insulin resistance, putting them at risk of developing type 2 diabetes in future. The mortality rates of acromegaly patients are three times higher than the general population, with most dying from respiratory or cardiac complications.

In this online, self-learning activity:

Over 64,000 people develop and close 50,000 die each year of pancreatic cancer, and by 2030, pancreatic cancer is expected to surpass colorectal and breast cancer to become the second-leading cause of cancer death. Over 90% of whom have pancreatic ductal adenocarcinoma (PDAC), and while the 5-year survival rate for patients diagnosed with localized disease is over 44%, patients with locally advanced (LAPC) or metastatic disease have a median overall survival of 12 to 14 months. Symptoms associated with pancreatic cancer are not usually evident in the early stages of the disease and may be intermittent and nonspecific, and more than half of patients have advanced disease by the time they are diagnosed.

In this online, self-learning activity:

Sickle cell disease (SCD) is the most common monogenic blood disorder, affecting millions of people worldwide and approximately 100,000 Americans. Although it may be found in various areas of the world, SCD predominantly affects individuals of African or Hispanic heritage. It is caused by the inheritance of b-globin alleles that code for hemoglobin S, resulting in an amino acid substitution in hemoglobin’s b chain and clinical disease. Patients with SCD have impaired circulation, and lysis of the erythrocytes contributes to a chronic inflammatory response, causing severe pain and less efficient oxygen delivery. The hallmark clinical features of SCD are hemolytic anemia and painful vaso-occlusive crises (VOCs), which may lead to emergency department (ED) visits, hospitalization, and potentially fatal complications. In one US study, 45% of deaths among people with SCD were related to cardiopulmonary causes, and VOCs alone have been shown to increase the risk of death by 50%. SCD also imposes other significant health burdens on patients: it is associated with a significant reduction in quality of life, malnutrition, the development of mental health disorders like depression and anxiety, loss of work or school days, frequent antibiotic use leading to higher rates of antimicrobial resistance, acute chest syndrome, and stroke.

In this 1-hour presentation, Dr. Charles Vega discusses the science behind multicancer early detection (MCED) testing and explores the benefits and limitations of MCED tests available for clinical use and undergoing investigation in clinical trials. Faculty also share practical clinical information on integrating MCED testing in current workflows, including identifying patients who are appropriate candidates for MCED testing, addressing patient concerns, and interpreting results. A guide to discussing MCED testing with patients is also provided.